Cellosaurus logo
expasy logo

Cellosaurus HAK-3 (CVCL_E419)

[Text][XML][JSON]
Cell line name HAK-3
Accession CVCL_E419
Resource Identification Initiative To cite this cell line use: HAK-3 (RRID:CVCL_E419)
Comments Population: Japanese.
Doubling time: ~26 hours (Note=At 52th passage) (PubMed=10493947).
Derived from site: In situ; Liver; UBERON=UBERON_0002107.
Disease Hepatitis C infection (NCIt: C3098)
Adult hepatocellular carcinoma (NCIt: C7956)
Adult hepatocellular carcinoma (ORDO: Orphanet_210159)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 63Y
Category Cancer cell line
Publications

PubMed=10347112; DOI=10.1002/hep.510290624
Hirohisa Yano, Akihiro Iemura, Makoto Haramaki, Sachiko Ogasawara, Akiko Takayama, Jun Akiba, Masamichi Kojiro;
Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
Hepatology 29:1708-1717(1999)

PubMed=10493947; DOI=10.3892/ijo.15.4.669
Itaru Utsunomiya, Akihiro Iemura, Hirohisa Yano, Jun Akiba, Masamichi Kojiro;
Establishment and characterization of a new human hepatocellular carcinoma cell line, HAK-3, and its response to growth factors.
Int. J. Oncol. 15:669-675(1999)

Cross-references
Encyclopedic resources Wikidata; Q54872382
Entry history
Entry creation22-Oct-2012
Last entry update29-Jun-2023
Version number10